119,181 iShares U.S. Pharmaceuticals ETF $IHE Shares Sold by Insight Wealth Strategies LLC

Insight Wealth Strategies LLC lessened its holdings in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) by 97.2% during the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 3,461 shares of the company’s stock after selling 119,181 shares during the quarter. Insight Wealth Strategies LLC’s holdings in iShares U.S. Pharmaceuticals ETF were worth $348,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Congress Asset Management Co. acquired a new stake in iShares U.S. Pharmaceuticals ETF in the third quarter valued at about $56,000. Root Financial Partners LLC grew its holdings in shares of iShares U.S. Pharmaceuticals ETF by 36.5% during the 1st quarter. Root Financial Partners LLC now owns 696 shares of the company’s stock valued at $60,000 after purchasing an additional 186 shares during the last quarter. Trust Co. of Vermont acquired a new position in iShares U.S. Pharmaceuticals ETF during the 2nd quarter worth approximately $60,000. Integrated Wealth Concepts LLC acquired a new position in iShares U.S. Pharmaceuticals ETF during the 2nd quarter worth approximately $75,000. Finally, Sunbelt Securities Inc. lifted its stake in iShares U.S. Pharmaceuticals ETF by 14.3% in the 1st quarter. Sunbelt Securities Inc. now owns 960 shares of the company’s stock valued at $83,000 after purchasing an additional 120 shares during the last quarter.

iShares U.S. Pharmaceuticals ETF Trading Up 1.3%

iShares U.S. Pharmaceuticals ETF stock traded up $1.32 during mid-day trading on Friday, reaching $100.18. The company had a trading volume of 109,617 shares, compared to its average volume of 164,446. The business has a fifty day simple moving average of $102.73 and a 200 day simple moving average of $96.04. The company has a market cap of $1.63 billion, a P/E ratio of 17.75 and a beta of 0.47. iShares U.S. Pharmaceuticals ETF has a fifty-two week low of $72.94 and a fifty-two week high of $108.66.

About iShares U.S. Pharmaceuticals ETF

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.